Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026(Status and Outlook)
Prenatal second-generation DNA sequencing refers to the cutting-edge prenatal screening method that uses high-throughput sequencing technology to analyze fetal free DNA in the peripheral blood of pregnant women, in order to detect fetal chromosomal abnormalities and genetic diseases. Compared to invasive examinations such as amniocentesis, this method has significant advantages of non invasiveness and high safety. In terms of clinical application, prenatal second-generation DNA sequencing has expanded from the initial screening for Down syndrome to include screening for sex chromosome abnormalities (such as Turner syndrome, Klinefelter syndrome), microdeletion/microduplication syndrome (such as 22q11.2 deletion syndrome), and some monogenic genetic diseases.
The global Prenatal Second-Generation DNA Sequencing market size was estimated at USD 1290.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prenatal Second-Generation DNA Sequencing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prenatal Second-Generation DNA Sequencing market.
Global Prenatal Second-Generation DNA Sequencing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Natera
Illumina
Quest Diagnostics
Ambry Genetics
PerkinEImer
Invitae
Neogenomics
Agilent Technologies
Sema4
Thermo Fisher Scientific
Fulgent Genetics
Genomics England
BGI Genomics
Berry Genomics
DAAN Gene
CapitalBio
Annoroad
MGI Tech
FANdi Biotechnology
BioMiao Biotechnology
JBP Medical
Market Segmentation (by Type)
Genome Sequencing
Targeted Sequencing
Market Segmentation (by Application)
High-Risk Pregnant Women Screening
Twin Pregnancy
Assisted Reproductive Technology Pregnancy
Low-Risk Pregnant Women Screening
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prenatal Second-Generation DNA Sequencing Market
Overview of the regional outlook of the Prenatal Second-Generation DNA Sequencing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prenatal Second-Generation DNA Sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prenatal Second-Generation DNA Sequencing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Prenatal Second-Generation DNA Sequencing market size was estimated at USD 1290.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Prenatal Second-Generation DNA Sequencing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Prenatal Second-Generation DNA Sequencing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prenatal Second-Generation DNA Sequencing market.
Global Prenatal Second-Generation DNA Sequencing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche
Natera
Illumina
Quest Diagnostics
Ambry Genetics
PerkinEImer
Invitae
Neogenomics
Agilent Technologies
Sema4
Thermo Fisher Scientific
Fulgent Genetics
Genomics England
BGI Genomics
Berry Genomics
DAAN Gene
CapitalBio
Annoroad
MGI Tech
FANdi Biotechnology
BioMiao Biotechnology
JBP Medical
Market Segmentation (by Type)
Genome Sequencing
Targeted Sequencing
Market Segmentation (by Application)
High-Risk Pregnant Women Screening
Twin Pregnancy
Assisted Reproductive Technology Pregnancy
Low-Risk Pregnant Women Screening
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prenatal Second-Generation DNA Sequencing Market
Overview of the regional outlook of the Prenatal Second-Generation DNA Sequencing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prenatal Second-Generation DNA Sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Prenatal Second-Generation DNA Sequencing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Prenatal Second-Generation DNA Sequencing
1.2 Key Market Segments
1.2.1 Prenatal Second-Generation DNA Sequencing Segment by Type
1.2.2 Prenatal Second-Generation DNA Sequencing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prenatal Second-Generation DNA Sequencing Product Life Cycle
3.3 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company (2020-2025)
3.4 Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Prenatal Second-Generation DNA Sequencing Market Competitive Situation and Trends
3.6.1 Prenatal Second-Generation DNA Sequencing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRENATAL SECOND-GENERATION DNA SEQUENCING VALUE CHAIN ANALYSIS
4.1 Prenatal Second-Generation DNA Sequencing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prenatal Second-Generation DNA Sequencing Market Porter's Five Forces Analysis
6 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prenatal Second-Generation DNA Sequencing Market by Type (2020-2025)
6.3 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
7 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) by Application (2020-2025)
7.3 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
8 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY REGION
8.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region
8.1.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region
8.1.2 Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region
8.2 North America
8.2.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prenatal Second-Generation DNA Sequencing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Basic Information
9.1.2 Roche Prenatal Second-Generation DNA Sequencing Product Overview
9.1.3 Roche Prenatal Second-Generation DNA Sequencing Product Market Performance
9.1.4 Roche SWOT Analysis
9.1.5 Roche Business Overview
9.1.6 Roche Recent Developments
9.2 Natera
9.2.1 Natera Basic Information
9.2.2 Natera Prenatal Second-Generation DNA Sequencing Product Overview
9.2.3 Natera Prenatal Second-Generation DNA Sequencing Product Market Performance
9.2.4 Natera SWOT Analysis
9.2.5 Natera Business Overview
9.2.6 Natera Recent Developments
9.3 Illumina
9.3.1 Illumina Basic Information
9.3.2 Illumina Prenatal Second-Generation DNA Sequencing Product Overview
9.3.3 Illumina Prenatal Second-Generation DNA Sequencing Product Market Performance
9.3.4 Illumina SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Basic Information
9.4.2 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Overview
9.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.4.4 Quest Diagnostics Business Overview
9.4.5 Quest Diagnostics Recent Developments
9.5 Ambry Genetics
9.5.1 Ambry Genetics Basic Information
9.5.2 Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Overview
9.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.5.4 Ambry Genetics Business Overview
9.5.5 Ambry Genetics Recent Developments
9.6 PerkinEImer
9.6.1 PerkinEImer Basic Information
9.6.2 PerkinEImer Prenatal Second-Generation DNA Sequencing Product Overview
9.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Product Market Performance
9.6.4 PerkinEImer Business Overview
9.6.5 PerkinEImer Recent Developments
9.7 Invitae
9.7.1 Invitae Basic Information
9.7.2 Invitae Prenatal Second-Generation DNA Sequencing Product Overview
9.7.3 Invitae Prenatal Second-Generation DNA Sequencing Product Market Performance
9.7.4 Invitae Business Overview
9.7.5 Invitae Recent Developments
9.8 Neogenomics
9.8.1 Neogenomics Basic Information
9.8.2 Neogenomics Prenatal Second-Generation DNA Sequencing Product Overview
9.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.8.4 Neogenomics Business Overview
9.8.5 Neogenomics Recent Developments
9.9 Agilent Technologies
9.9.1 Agilent Technologies Basic Information
9.9.2 Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Overview
9.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Market Performance
9.9.4 Agilent Technologies Business Overview
9.9.5 Agilent Technologies Recent Developments
9.10 Sema4
9.10.1 Sema4 Basic Information
9.10.2 Sema4 Prenatal Second-Generation DNA Sequencing Product Overview
9.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Product Market Performance
9.10.4 Sema4 Business Overview
9.10.5 Sema4 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Basic Information
9.11.2 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Overview
9.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Market Performance
9.11.4 Thermo Fisher Scientific Business Overview
9.11.5 Thermo Fisher Scientific Recent Developments
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Basic Information
9.12.2 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Overview
9.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.12.4 Fulgent Genetics Business Overview
9.12.5 Fulgent Genetics Recent Developments
9.13 Genomics England
9.13.1 Genomics England Basic Information
9.13.2 Genomics England Prenatal Second-Generation DNA Sequencing Product Overview
9.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Product Market Performance
9.13.4 Genomics England Business Overview
9.13.5 Genomics England Recent Developments
9.14 BGI Genomics
9.14.1 BGI Genomics Basic Information
9.14.2 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Overview
9.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.14.4 BGI Genomics Business Overview
9.14.5 BGI Genomics Recent Developments
9.15 Berry Genomics
9.15.1 Berry Genomics Basic Information
9.15.2 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Overview
9.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.15.4 Berry Genomics Business Overview
9.15.5 Berry Genomics Recent Developments
9.16 DAAN Gene
9.16.1 DAAN Gene Basic Information
9.16.2 DAAN Gene Prenatal Second-Generation DNA Sequencing Product Overview
9.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Product Market Performance
9.16.4 DAAN Gene Business Overview
9.16.5 DAAN Gene Recent Developments
9.17 CapitalBio
9.17.1 CapitalBio Basic Information
9.17.2 CapitalBio Prenatal Second-Generation DNA Sequencing Product Overview
9.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Product Market Performance
9.17.4 CapitalBio Business Overview
9.17.5 CapitalBio Recent Developments
9.18 Annoroad
9.18.1 Annoroad Basic Information
9.18.2 Annoroad Prenatal Second-Generation DNA Sequencing Product Overview
9.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Product Market Performance
9.18.4 Annoroad Business Overview
9.18.5 Annoroad Recent Developments
9.19 MGI Tech
9.19.1 MGI Tech Basic Information
9.19.2 MGI Tech Prenatal Second-Generation DNA Sequencing Product Overview
9.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Product Market Performance
9.19.4 MGI Tech Business Overview
9.19.5 MGI Tech Recent Developments
9.20 FANdi Biotechnology
9.20.1 FANdi Biotechnology Basic Information
9.20.2 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
9.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Market Performance
9.20.4 FANdi Biotechnology Business Overview
9.20.5 FANdi Biotechnology Recent Developments
9.21 BioMiao Biotechnology
9.21.1 BioMiao Biotechnology Basic Information
9.21.2 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
9.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Market Performance
9.21.4 BioMiao Biotechnology Business Overview
9.21.5 BioMiao Biotechnology Recent Developments
9.22 JBP Medical
9.22.1 JBP Medical Basic Information
9.22.2 JBP Medical Prenatal Second-Generation DNA Sequencing Product Overview
9.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Product Market Performance
9.22.4 JBP Medical Business Overview
9.22.5 JBP Medical Recent Developments
10 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET FORECAST BY REGION
10.1 Global Prenatal Second-Generation DNA Sequencing Market Size Forecast
10.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country
10.2.3 Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region
10.2.4 South America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Prenatal Second-Generation DNA Sequencing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Type (2026-2035)
11.1.1 Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Type (2026-2035)
11.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Application (2026-2035)
11.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Prenatal Second-Generation DNA Sequencing
1.2 Key Market Segments
1.2.1 Prenatal Second-Generation DNA Sequencing Segment by Type
1.2.2 Prenatal Second-Generation DNA Sequencing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Prenatal Second-Generation DNA Sequencing Product Life Cycle
3.3 Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company (2020-2025)
3.4 Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Prenatal Second-Generation DNA Sequencing Market Competitive Situation and Trends
3.6.1 Prenatal Second-Generation DNA Sequencing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prenatal Second-Generation DNA Sequencing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRENATAL SECOND-GENERATION DNA SEQUENCING VALUE CHAIN ANALYSIS
4.1 Prenatal Second-Generation DNA Sequencing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Prenatal Second-Generation DNA Sequencing Market Porter's Five Forces Analysis
6 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prenatal Second-Generation DNA Sequencing Market by Type (2020-2025)
6.3 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
7 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) by Application (2020-2025)
7.3 Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
8 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET SEGMENTATION BY REGION
8.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region
8.1.1 Global Prenatal Second-Generation DNA Sequencing Market Size by Region
8.1.2 Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region
8.2 North America
8.2.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prenatal Second-Generation DNA Sequencing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Basic Information
9.1.2 Roche Prenatal Second-Generation DNA Sequencing Product Overview
9.1.3 Roche Prenatal Second-Generation DNA Sequencing Product Market Performance
9.1.4 Roche SWOT Analysis
9.1.5 Roche Business Overview
9.1.6 Roche Recent Developments
9.2 Natera
9.2.1 Natera Basic Information
9.2.2 Natera Prenatal Second-Generation DNA Sequencing Product Overview
9.2.3 Natera Prenatal Second-Generation DNA Sequencing Product Market Performance
9.2.4 Natera SWOT Analysis
9.2.5 Natera Business Overview
9.2.6 Natera Recent Developments
9.3 Illumina
9.3.1 Illumina Basic Information
9.3.2 Illumina Prenatal Second-Generation DNA Sequencing Product Overview
9.3.3 Illumina Prenatal Second-Generation DNA Sequencing Product Market Performance
9.3.4 Illumina SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Basic Information
9.4.2 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Overview
9.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.4.4 Quest Diagnostics Business Overview
9.4.5 Quest Diagnostics Recent Developments
9.5 Ambry Genetics
9.5.1 Ambry Genetics Basic Information
9.5.2 Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Overview
9.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.5.4 Ambry Genetics Business Overview
9.5.5 Ambry Genetics Recent Developments
9.6 PerkinEImer
9.6.1 PerkinEImer Basic Information
9.6.2 PerkinEImer Prenatal Second-Generation DNA Sequencing Product Overview
9.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Product Market Performance
9.6.4 PerkinEImer Business Overview
9.6.5 PerkinEImer Recent Developments
9.7 Invitae
9.7.1 Invitae Basic Information
9.7.2 Invitae Prenatal Second-Generation DNA Sequencing Product Overview
9.7.3 Invitae Prenatal Second-Generation DNA Sequencing Product Market Performance
9.7.4 Invitae Business Overview
9.7.5 Invitae Recent Developments
9.8 Neogenomics
9.8.1 Neogenomics Basic Information
9.8.2 Neogenomics Prenatal Second-Generation DNA Sequencing Product Overview
9.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.8.4 Neogenomics Business Overview
9.8.5 Neogenomics Recent Developments
9.9 Agilent Technologies
9.9.1 Agilent Technologies Basic Information
9.9.2 Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Overview
9.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Market Performance
9.9.4 Agilent Technologies Business Overview
9.9.5 Agilent Technologies Recent Developments
9.10 Sema4
9.10.1 Sema4 Basic Information
9.10.2 Sema4 Prenatal Second-Generation DNA Sequencing Product Overview
9.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Product Market Performance
9.10.4 Sema4 Business Overview
9.10.5 Sema4 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Basic Information
9.11.2 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Overview
9.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Market Performance
9.11.4 Thermo Fisher Scientific Business Overview
9.11.5 Thermo Fisher Scientific Recent Developments
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Basic Information
9.12.2 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Overview
9.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.12.4 Fulgent Genetics Business Overview
9.12.5 Fulgent Genetics Recent Developments
9.13 Genomics England
9.13.1 Genomics England Basic Information
9.13.2 Genomics England Prenatal Second-Generation DNA Sequencing Product Overview
9.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Product Market Performance
9.13.4 Genomics England Business Overview
9.13.5 Genomics England Recent Developments
9.14 BGI Genomics
9.14.1 BGI Genomics Basic Information
9.14.2 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Overview
9.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.14.4 BGI Genomics Business Overview
9.14.5 BGI Genomics Recent Developments
9.15 Berry Genomics
9.15.1 Berry Genomics Basic Information
9.15.2 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Overview
9.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product Market Performance
9.15.4 Berry Genomics Business Overview
9.15.5 Berry Genomics Recent Developments
9.16 DAAN Gene
9.16.1 DAAN Gene Basic Information
9.16.2 DAAN Gene Prenatal Second-Generation DNA Sequencing Product Overview
9.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Product Market Performance
9.16.4 DAAN Gene Business Overview
9.16.5 DAAN Gene Recent Developments
9.17 CapitalBio
9.17.1 CapitalBio Basic Information
9.17.2 CapitalBio Prenatal Second-Generation DNA Sequencing Product Overview
9.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Product Market Performance
9.17.4 CapitalBio Business Overview
9.17.5 CapitalBio Recent Developments
9.18 Annoroad
9.18.1 Annoroad Basic Information
9.18.2 Annoroad Prenatal Second-Generation DNA Sequencing Product Overview
9.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Product Market Performance
9.18.4 Annoroad Business Overview
9.18.5 Annoroad Recent Developments
9.19 MGI Tech
9.19.1 MGI Tech Basic Information
9.19.2 MGI Tech Prenatal Second-Generation DNA Sequencing Product Overview
9.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Product Market Performance
9.19.4 MGI Tech Business Overview
9.19.5 MGI Tech Recent Developments
9.20 FANdi Biotechnology
9.20.1 FANdi Biotechnology Basic Information
9.20.2 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
9.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Market Performance
9.20.4 FANdi Biotechnology Business Overview
9.20.5 FANdi Biotechnology Recent Developments
9.21 BioMiao Biotechnology
9.21.1 BioMiao Biotechnology Basic Information
9.21.2 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
9.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Market Performance
9.21.4 BioMiao Biotechnology Business Overview
9.21.5 BioMiao Biotechnology Recent Developments
9.22 JBP Medical
9.22.1 JBP Medical Basic Information
9.22.2 JBP Medical Prenatal Second-Generation DNA Sequencing Product Overview
9.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Product Market Performance
9.22.4 JBP Medical Business Overview
9.22.5 JBP Medical Recent Developments
10 PRENATAL SECOND-GENERATION DNA SEQUENCING MARKET FORECAST BY REGION
10.1 Global Prenatal Second-Generation DNA Sequencing Market Size Forecast
10.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country
10.2.3 Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region
10.2.4 South America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Prenatal Second-Generation DNA Sequencing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Type (2026-2035)
11.1.1 Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Type (2026-2035)
11.2 Global Prenatal Second-Generation DNA Sequencing Market Forecast by Application (2026-2035)
11.2.1 Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (M USD)
Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size by Application
Table 5. Prenatal Second-Generation DNA Sequencing Market Size Comparison by Region (M USD)
Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue (M USD) by Company (2020-2025)
Table 7. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Prenatal Second-Generation DNA Sequencing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Prenatal Second-Generation DNA Sequencing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (M USD)
Table 22. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) by Type (2020-2025)
Table 23. Global Prenatal Second-Generation DNA Sequencing Market Share by Type (2020-2025)
Table 24. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Prenatal Second-Generation DNA Sequencing Market Size by Application
Table 26. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Prenatal Second-Generation DNA Sequencing Market Share by Application (2020-2025)
Table 28. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region (2020-2025)
Table 31. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 36. Roche Basic Information
Table 37. Roche Prenatal Second-Generation DNA Sequencing Product Overview
Table 38. Roche Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Roche SWOT Analysis
Table 40. Roche Business Overview
Table 41. Roche Recent Developments
Table 42. Natera Basic Information
Table 43. Natera Prenatal Second-Generation DNA Sequencing Product Overview
Table 44. Natera Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Natera SWOT Analysis
Table 46. Natera Business Overview
Table 47. Natera Recent Developments
Table 48. Illumina Basic Information
Table 49. Illumina Prenatal Second-Generation DNA Sequencing Product Overview
Table 50. Illumina Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Illumina SWOT Analysis
Table 52. Illumina Business Overview
Table 53. Illumina Recent Developments
Table 54. Quest Diagnostics Basic Information
Table 55. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Overview
Table 56. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Quest Diagnostics Business Overview
Table 58. Quest Diagnostics Recent Developments
Table 59. Ambry Genetics Basic Information
Table 60. Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Overview
Table 61. Ambry Genetics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Ambry Genetics Business Overview
Table 63. Ambry Genetics Recent Developments
Table 64. PerkinEImer Basic Information
Table 65. PerkinEImer Prenatal Second-Generation DNA Sequencing Product Overview
Table 66. PerkinEImer Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. PerkinEImer Business Overview
Table 68. PerkinEImer Recent Developments
Table 69. Invitae Basic Information
Table 70. Invitae Prenatal Second-Generation DNA Sequencing Product Overview
Table 71. Invitae Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Invitae Business Overview
Table 73. Invitae Recent Developments
Table 74. Neogenomics Basic Information
Table 75. Neogenomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 76. Neogenomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Neogenomics Business Overview
Table 78. Neogenomics Recent Developments
Table 79. Agilent Technologies Basic Information
Table 80. Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Overview
Table 81. Agilent Technologies Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Recent Developments
Table 84. Sema4 Basic Information
Table 85. Sema4 Prenatal Second-Generation DNA Sequencing Product Overview
Table 86. Sema4 Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Sema4 Business Overview
Table 88. Sema4 Recent Developments
Table 89. Thermo Fisher Scientific Basic Information
Table 90. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Overview
Table 91. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. Fulgent Genetics Basic Information
Table 95. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Overview
Table 96. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Fulgent Genetics Business Overview
Table 98. Fulgent Genetics Recent Developments
Table 99. Genomics England Basic Information
Table 100. Genomics England Prenatal Second-Generation DNA Sequencing Product Overview
Table 101. Genomics England Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Genomics England Business Overview
Table 103. Genomics England Recent Developments
Table 104. BGI Genomics Basic Information
Table 105. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 106. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. BGI Genomics Business Overview
Table 108. BGI Genomics Recent Developments
Table 109. Berry Genomics Basic Information
Table 110. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 111. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Berry Genomics Business Overview
Table 113. Berry Genomics Recent Developments
Table 114. DAAN Gene Basic Information
Table 115. DAAN Gene Prenatal Second-Generation DNA Sequencing Product Overview
Table 116. DAAN Gene Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 117. DAAN Gene Business Overview
Table 118. DAAN Gene Recent Developments
Table 119. CapitalBio Basic Information
Table 120. CapitalBio Prenatal Second-Generation DNA Sequencing Product Overview
Table 121. CapitalBio Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 122. CapitalBio Business Overview
Table 123. CapitalBio Recent Developments
Table 124. Annoroad Basic Information
Table 125. Annoroad Prenatal Second-Generation DNA Sequencing Product Overview
Table 126. Annoroad Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Annoroad Business Overview
Table 128. Annoroad Recent Developments
Table 129. MGI Tech Basic Information
Table 130. MGI Tech Prenatal Second-Generation DNA Sequencing Product Overview
Table 131. MGI Tech Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 132. MGI Tech Business Overview
Table 133. MGI Tech Recent Developments
Table 134. FANdi Biotechnology Basic Information
Table 135. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
Table 136. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 137. FANdi Biotechnology Business Overview
Table 138. FANdi Biotechnology Recent Developments
Table 139. BioMiao Biotechnology Basic Information
Table 140. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
Table 141. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 142. BioMiao Biotechnology Business Overview
Table 143. BioMiao Biotechnology Recent Developments
Table 144. JBP Medical Basic Information
Table 145. JBP Medical Prenatal Second-Generation DNA Sequencing Product Overview
Table 146. JBP Medical Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 147. JBP Medical Business Overview
Table 148. JBP Medical Recent Developments
Table 149. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region (2026-2035) & (M USD)
Table 150. North America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Type (2026-2035) & (M USD)
Table 156. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (M USD)
Table 4. Global Prenatal Second-Generation DNA Sequencing Market Size by Application
Table 5. Prenatal Second-Generation DNA Sequencing Market Size Comparison by Region (M USD)
Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue (M USD) by Company (2020-2025)
Table 7. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Prenatal Second-Generation DNA Sequencing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Prenatal Second-Generation DNA Sequencing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (M USD)
Table 22. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) by Type (2020-2025)
Table 23. Global Prenatal Second-Generation DNA Sequencing Market Share by Type (2020-2025)
Table 24. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Prenatal Second-Generation DNA Sequencing Market Size by Application
Table 26. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Prenatal Second-Generation DNA Sequencing Market Share by Application (2020-2025)
Table 28. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region (2020-2025)
Table 31. North America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Prenatal Second-Generation DNA Sequencing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size by Region (2020-2025) & (M USD)
Table 36. Roche Basic Information
Table 37. Roche Prenatal Second-Generation DNA Sequencing Product Overview
Table 38. Roche Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Roche SWOT Analysis
Table 40. Roche Business Overview
Table 41. Roche Recent Developments
Table 42. Natera Basic Information
Table 43. Natera Prenatal Second-Generation DNA Sequencing Product Overview
Table 44. Natera Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Natera SWOT Analysis
Table 46. Natera Business Overview
Table 47. Natera Recent Developments
Table 48. Illumina Basic Information
Table 49. Illumina Prenatal Second-Generation DNA Sequencing Product Overview
Table 50. Illumina Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Illumina SWOT Analysis
Table 52. Illumina Business Overview
Table 53. Illumina Recent Developments
Table 54. Quest Diagnostics Basic Information
Table 55. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product Overview
Table 56. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Quest Diagnostics Business Overview
Table 58. Quest Diagnostics Recent Developments
Table 59. Ambry Genetics Basic Information
Table 60. Ambry Genetics Prenatal Second-Generation DNA Sequencing Product Overview
Table 61. Ambry Genetics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Ambry Genetics Business Overview
Table 63. Ambry Genetics Recent Developments
Table 64. PerkinEImer Basic Information
Table 65. PerkinEImer Prenatal Second-Generation DNA Sequencing Product Overview
Table 66. PerkinEImer Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. PerkinEImer Business Overview
Table 68. PerkinEImer Recent Developments
Table 69. Invitae Basic Information
Table 70. Invitae Prenatal Second-Generation DNA Sequencing Product Overview
Table 71. Invitae Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Invitae Business Overview
Table 73. Invitae Recent Developments
Table 74. Neogenomics Basic Information
Table 75. Neogenomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 76. Neogenomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Neogenomics Business Overview
Table 78. Neogenomics Recent Developments
Table 79. Agilent Technologies Basic Information
Table 80. Agilent Technologies Prenatal Second-Generation DNA Sequencing Product Overview
Table 81. Agilent Technologies Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Recent Developments
Table 84. Sema4 Basic Information
Table 85. Sema4 Prenatal Second-Generation DNA Sequencing Product Overview
Table 86. Sema4 Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Sema4 Business Overview
Table 88. Sema4 Recent Developments
Table 89. Thermo Fisher Scientific Basic Information
Table 90. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Product Overview
Table 91. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. Fulgent Genetics Basic Information
Table 95. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product Overview
Table 96. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Fulgent Genetics Business Overview
Table 98. Fulgent Genetics Recent Developments
Table 99. Genomics England Basic Information
Table 100. Genomics England Prenatal Second-Generation DNA Sequencing Product Overview
Table 101. Genomics England Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Genomics England Business Overview
Table 103. Genomics England Recent Developments
Table 104. BGI Genomics Basic Information
Table 105. BGI Genomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 106. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 107. BGI Genomics Business Overview
Table 108. BGI Genomics Recent Developments
Table 109. Berry Genomics Basic Information
Table 110. Berry Genomics Prenatal Second-Generation DNA Sequencing Product Overview
Table 111. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Berry Genomics Business Overview
Table 113. Berry Genomics Recent Developments
Table 114. DAAN Gene Basic Information
Table 115. DAAN Gene Prenatal Second-Generation DNA Sequencing Product Overview
Table 116. DAAN Gene Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 117. DAAN Gene Business Overview
Table 118. DAAN Gene Recent Developments
Table 119. CapitalBio Basic Information
Table 120. CapitalBio Prenatal Second-Generation DNA Sequencing Product Overview
Table 121. CapitalBio Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 122. CapitalBio Business Overview
Table 123. CapitalBio Recent Developments
Table 124. Annoroad Basic Information
Table 125. Annoroad Prenatal Second-Generation DNA Sequencing Product Overview
Table 126. Annoroad Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Annoroad Business Overview
Table 128. Annoroad Recent Developments
Table 129. MGI Tech Basic Information
Table 130. MGI Tech Prenatal Second-Generation DNA Sequencing Product Overview
Table 131. MGI Tech Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 132. MGI Tech Business Overview
Table 133. MGI Tech Recent Developments
Table 134. FANdi Biotechnology Basic Information
Table 135. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
Table 136. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 137. FANdi Biotechnology Business Overview
Table 138. FANdi Biotechnology Recent Developments
Table 139. BioMiao Biotechnology Basic Information
Table 140. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Product Overview
Table 141. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 142. BioMiao Biotechnology Business Overview
Table 143. BioMiao Biotechnology Recent Developments
Table 144. JBP Medical Basic Information
Table 145. JBP Medical Prenatal Second-Generation DNA Sequencing Product Overview
Table 146. JBP Medical Prenatal Second-Generation DNA Sequencing Revenue (M USD) and Gross Margin (2020-2025)
Table 147. JBP Medical Business Overview
Table 148. JBP Medical Recent Developments
Table 149. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region (2026-2035) & (M USD)
Table 150. North America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Europe Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Type (2026-2035) & (M USD)
Table 156. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Prenatal Second-Generation DNA Sequencing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD), 2025-2035
Figure 5. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Prenatal Second-Generation DNA Sequencing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Prenatal Second-Generation DNA Sequencing Product Life Cycle
Figure 12. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Company in 2025
Figure 13. Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2025
Figure 15. Value Chain Map of Prenatal Second-Generation DNA Sequencing
Figure 16. Global Prenatal Second-Generation DNA Sequencing Market PEST Analysis
Figure 17. Global Prenatal Second-Generation DNA Sequencing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Prenatal Second-Generation DNA Sequencing Market Share by Type
Figure 20. Market Share of Prenatal Second-Generation DNA Sequencing by Type (2020-2025)
Figure 21. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prenatal Second-Generation DNA Sequencing Market Share by Application
Figure 24. Global Prenatal Second-Generation DNA Sequencing Market Share by Application (2020-2025)
Figure 25. Global Prenatal Second-Generation DNA Sequencing Market Share by Application in 2024
Figure 26. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region (2020-2025)
Figure 28. North America Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Prenatal Second-Generation DNA Sequencing Market Size Market Share by Country in 2024
Figure 30. U.S. Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Prenatal Second-Generation DNA Sequencing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Prenatal Second-Generation DNA Sequencing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country in 2024
Figure 35. Germany Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region in 2024
Figure 42. China Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 48. South America Prenatal Second-Generation DNA Sequencing Market Size Market Share by Country in 2024
Figure 49. Brazil Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Prenatal Second-Generation DNA Sequencing Market Share Forecast by Type (2026-2035)
Figure 61. Global Prenatal Second-Generation DNA Sequencing Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Prenatal Second-Generation DNA Sequencing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD), 2025-2035
Figure 5. Global Prenatal Second-Generation DNA Sequencing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Prenatal Second-Generation DNA Sequencing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Prenatal Second-Generation DNA Sequencing Product Life Cycle
Figure 12. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Company in 2025
Figure 13. Prenatal Second-Generation DNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2025
Figure 15. Value Chain Map of Prenatal Second-Generation DNA Sequencing
Figure 16. Global Prenatal Second-Generation DNA Sequencing Market PEST Analysis
Figure 17. Global Prenatal Second-Generation DNA Sequencing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Prenatal Second-Generation DNA Sequencing Market Share by Type
Figure 20. Market Share of Prenatal Second-Generation DNA Sequencing by Type (2020-2025)
Figure 21. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prenatal Second-Generation DNA Sequencing Market Share by Application
Figure 24. Global Prenatal Second-Generation DNA Sequencing Market Share by Application (2020-2025)
Figure 25. Global Prenatal Second-Generation DNA Sequencing Market Share by Application in 2024
Figure 26. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region (2020-2025)
Figure 28. North America Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Prenatal Second-Generation DNA Sequencing Market Size Market Share by Country in 2024
Figure 30. U.S. Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Prenatal Second-Generation DNA Sequencing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Prenatal Second-Generation DNA Sequencing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Prenatal Second-Generation DNA Sequencing Market Share by Country in 2024
Figure 35. Germany Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region in 2024
Figure 42. China Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 48. South America Prenatal Second-Generation DNA Sequencing Market Size Market Share by Country in 2024
Figure 49. Brazil Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Prenatal Second-Generation DNA Sequencing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Prenatal Second-Generation DNA Sequencing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Prenatal Second-Generation DNA Sequencing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Prenatal Second-Generation DNA Sequencing Market Share Forecast by Type (2026-2035)
Figure 61. Global Prenatal Second-Generation DNA Sequencing Market Share Forecast by Application (2026-2035)
